Breaks Categories: News

MondaySep 18, 2023 11:40 am

BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Interim Results from FIH Clinical Trial of Lucid-MS

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today announced the receipt of an interim report for the first-in-human (“FIH”) single ascending dose phase I clinical trial evaluating the company’s novel drug candidate. The interim blinded report for Lucid-21-302 (“Lucid-MS”), an orally administered treatment for multiple sclerosis ("MS"), was issued on Aug, 17, 2023, for the first four cohorts, with an addendum report describing the results of the fifth cohort due by the end of the month. “We are…

Continue Reading

FridaySep 15, 2023 11:59 am

BioMedNewsBreaks – Safety Shot (NASDAQ: SHOT) Rebrands with New Name, Ticker to Focus on New Business

Safety Shot (NASDAQ: SHOT), formerly known as Jupiter Wellness, has announced that effective today it has changed its name to Safety Shot; its ticker will also change to SHOT. The changes come after the company acquired Safety Shot, the first patented beverage that helps a person feel better faster by reducing blood alcohol content while also boosting clarity. The new beverage is currently being produced in the United States and will be available in the Q4 2023. Safety Shot is a patented beverage that helps to break down alcohol faster which aids in aiding in recovery and rehydration. Safety Shot is creating…

Continue Reading

FridaySep 15, 2023 11:48 am

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces $1.33M Registered Direct

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases. The company today announced its entry into a definitive agreement for the purchase and sale of 1,146,552 of the company’s American Depositary Shares (“ADSs”) (or ADS equivalents), each ADS representing 400 ordinary shares, at a purchase price of yesterday’s closing price of $1.16 per ADS (or ADS equivalent), in a registered direct offering. In addition, the company will issue unregistered warrants to purchase up to 1,146,552 ADSs representing ordinary shares…

Continue Reading

ThursdaySep 14, 2023 1:49 pm

BioMedNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Collaborates to Unlock the Value of Brands Through Strategic Acquisitions

Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery, and manufacturing of psychotropic products, recently announced the acquisition of BlueSky Wellness Inc., along with its portfolio of brands, which adds psychotropic products to its catalog and expands its footprint into the global wellness market. BlueSky wellness-focused ecommerce brands include Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which, in each of the last two years, have generated over $20 million in revenue. BlueSky is poised with a variety of products that range from full-spectrum oils to edible goods, gummies, topicals and beauty products. The…

Continue Reading

ThursdaySep 14, 2023 12:09 pm

BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Issues Update on Nasdaq Compliance Status

Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provided an update regarding the status of its compliance with continued listed standards and anticipated next steps to maintain its listing on the Nasdaq Capital Market. As previously announced, Nemaura was notified by letters dated April 3 and April 7, 2023, that the company no longer satisfied the minimum market value of listed securities and bid price requirements for continued listing on The Nasdaq Capital Market and, accordingly, was granted 180-day grace periods to regain compliance with…

Continue Reading

ThursdaySep 14, 2023 11:33 am

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Plaque Psoriasis Treatment Study

Scinai Immunotherapeutics(NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, is reporting encouraging results from its preclinical study of Scinai’s anti‑interleukin 17 (IL‑17) NanoAbs as a treatment for plaque psoriasis. According to the report, study results suggest that the NanoAbs, or nanosized VHH antibodies, have potential to relieve symptoms of plaque psoriasis. Currently, there is no safe, affordable biological drug available to treat mild psoriasis, which accounts for 50% of plaque psoriatic patients, has no safe and affordable biological drug available. Scinai’s…

Continue Reading

WednesdaySep 13, 2023 12:54 pm

BioMedNewsBreaks – Aqualab Marks Pivotal Moment with Rebranding, Strategic Reorganization

METER Food today announced its rebranding as Aqualab. The rebranding by the acclaimed pioneer in water activity and moisture content measurement solutions for food and pharma companies marks a pivotal moment in its trajectory. The transformation is part of a strategic reorganization by METER Group, which has consolidated its food-tech and agritech entities under a new holding company, Addium. The transition empowers Aqualab, along with sister companies POMETA and AROYA, to continue rapid expansion while bolstering an overall focus on data intelligence, science, software and sensors. “Aqualab’s journey has been a testament to our dedication to innovation and precision in food production,”…

Continue Reading

WednesdaySep 13, 2023 11:15 am

BioMedNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Announces Acquisition of BlueSky Wellness, Expands Footprint in Global Wellness Market

Lucy Scientific Discovery (NASDAQ: LSDI), a publicly traded company focused on the development, sale, delivery and manufacturing of psychotropic products, is acquiring BlueSky Wellness Inc. and the BlueSky portfolio of brands. According to the announcement, the acquisition adds psychotropic products to the company’s catalog, enabling LSDI to expand its footprint in the global wellness market. BlueSky Wellness brands include Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which have generated more than $20 million in revenue in each of the last two years; BlueSky products range from full-spectrum oils to edible goods, gummies, topicals and beauty products. As part of…

Continue Reading

WednesdaySep 13, 2023 10:18 am

BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Coverage Initiated by Singular Research

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders. The company today announced that Singular Research has initiated analyst coverage on FSD Pharma. The company has not paid for the research report prepared by Singular Research, and all reports on FSD Pharma prepared by analysts represent the views of such analysts and are not necessarily those of FSD Pharma. A copy of the report can be obtained directly from the analyst at Singular Research by contacting BJ…

Continue Reading

TuesdaySep 12, 2023 10:12 am

BioMedNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) to Acquire BlueSky Wellness Inc. in All-Stock Transaction

Lucy Scientific Discovery (NASDAQ: LSDI) is the leader in the psychotropic industry, which recently celebrated the acquisition of the intellectual property of High Times, the most iconic brand in the cannabis industry. Today the company announced an agreement to acquire BlueSky Wellness Inc. and its portfolio of brands, expanding Lucy’s footprint into the growing global wellness category by adding psychotropic products to its capabilities. BlueSky Wellness is a portfolio of plant-based brands including Keoni, Keoni Sport, Blush Wellness and AMMA Healing. It has generated over $20 million in each of the last two years through its e-commerce brands that are…

Continue Reading